# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318306-14-000006
Filing Date
2014-03-26
Accepted
2014-03-26 17:01:41
Documents
12
Period of Report
2013-12-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-K | a10k-123113.htm | 10-K | 1137817
2 | SUBSIDIARIES | ex_21.htm | EX-21 | 3911
3 | AUDITORS CONSENT | ex_23-1.htm | EX-23.1 | 4064
4 | CEO CERTIFICATION | ex_31-1.htm | EX-31.1 | 22518
5 | CFO CERTIFICATION | ex_31-2.htm | EX-31.2 | 21294
6 | CEO-CFO CERTIFICATION | ex_32.htm | EX-32 | 7842
| Complete submission text file | 0000318306-14-000006.txt |  | 7368387

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL INSTANCE DOCUMENTS | accp-20131231.xml | EX-101.INS | 1071232
8 | XBRL TAXONOMY SCHEMA | accp-20131231.xsd | EX-101.SCH | 44032
9 | XBRL CALCULATION LINKBASE | accp-20131231_cal.xml | EX-101.CAL | 60818
10 | XBRL DEFINITION LINKBASE | accp-20131231_def.xml | EX-101.DEF | 232977
11 | XBRL LABEL LINKBASE | accp-20131231_lab.xml | EX-101.LAB | 673800
12 | XBRL PRESENTATION LINKBASE | accp-20131231_pre.xml | EX-101.PRE | 376744

Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1025
Type: 10-K | Act: 34 | File No.: 001-15771 | Film No.: 14719277
SIC: 2834 Pharmaceutical Preparations